JPWO2024029630A1 - - Google Patents
Info
- Publication number
- JPWO2024029630A1 JPWO2024029630A1 JP2024539226A JP2024539226A JPWO2024029630A1 JP WO2024029630 A1 JPWO2024029630 A1 JP WO2024029630A1 JP 2024539226 A JP2024539226 A JP 2024539226A JP 2024539226 A JP2024539226 A JP 2024539226A JP WO2024029630 A1 JPWO2024029630 A1 JP WO2024029630A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022124810 | 2022-08-04 | ||
| JP2022159060 | 2022-09-30 | ||
| PCT/JP2023/028632 WO2024029630A1 (ja) | 2022-08-04 | 2023-08-04 | 環状ペプチド誘導体とその製造方法および組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2024029630A1 true JPWO2024029630A1 (https=) | 2024-02-08 |
Family
ID=89849507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539226A Pending JPWO2024029630A1 (https=) | 2022-08-04 | 2023-08-04 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20260035407A1 (https=) |
| EP (1) | EP4567042A1 (https=) |
| JP (1) | JPWO2024029630A1 (https=) |
| KR (1) | KR20250044905A (https=) |
| CN (1) | CN119731193A (https=) |
| AU (1) | AU2023317392A1 (https=) |
| CO (1) | CO2025001948A2 (https=) |
| IL (1) | IL318676A (https=) |
| MX (1) | MX2025001373A (https=) |
| PE (1) | PE20250797A1 (https=) |
| TW (1) | TW202423948A (https=) |
| WO (1) | WO2024029630A1 (https=) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
| GB9217295D0 (en) | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
| US5541231A (en) | 1993-07-30 | 1996-07-30 | Glaxo Wellcome Inc. | Stabilized Pharmaceutical |
| GB9315856D0 (en) | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
| US5358970A (en) | 1993-08-12 | 1994-10-25 | Burroughs Wellcome Co. | Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| DE69839355T2 (de) | 1997-07-29 | 2009-06-04 | Alcon Laboratories, Inc., Fort Worth | Ophthalmische Zusammensetzungen enthaltend Galaktomannanpolymere und Borat |
| AU2483599A (en) | 1998-01-29 | 1999-08-16 | Sepracor, Inc. | Pharmaceutical uses of optically pure (-)-bupropion |
| US8889112B2 (en) | 1999-09-16 | 2014-11-18 | Ocularis Pharma, Llc | Ophthalmic formulations including selective alpha 1 antagonists |
| US6933289B2 (en) | 2003-07-01 | 2005-08-23 | Allergan, Inc. | Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
| EP1654002B2 (en) | 2003-08-07 | 2014-01-29 | Allergan, Inc. | Compositions for delivery of therapeutics into the eyes |
| US20050059744A1 (en) | 2003-09-12 | 2005-03-17 | Allergan, Inc. | Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| WO2016047638A1 (ja) * | 2014-09-24 | 2016-03-31 | 国立大学法人岩手大学 | 環状ペプチド誘導体とその製造方法および組成物 |
| JP7486328B2 (ja) * | 2020-03-05 | 2024-05-17 | 株式会社バイオコクーン研究所 | 神経突起伸長促進剤、神経細胞の樹状突起発現促進剤、及び神経栄養因子様作用物質 |
| JP7695662B2 (ja) * | 2020-11-02 | 2025-06-19 | 公立大学法人大阪 | 環状ペプチド誘導体の製造方法及び環状ペプチド化合物の製造方法 |
-
2023
- 2023-08-04 US US19/100,630 patent/US20260035407A1/en active Pending
- 2023-08-04 IL IL318676A patent/IL318676A/en unknown
- 2023-08-04 EP EP23850183.7A patent/EP4567042A1/en active Pending
- 2023-08-04 TW TW112129422A patent/TW202423948A/zh unknown
- 2023-08-04 AU AU2023317392A patent/AU2023317392A1/en active Pending
- 2023-08-04 KR KR1020257006892A patent/KR20250044905A/ko active Pending
- 2023-08-04 JP JP2024539226A patent/JPWO2024029630A1/ja active Pending
- 2023-08-04 WO PCT/JP2023/028632 patent/WO2024029630A1/ja not_active Ceased
- 2023-08-04 PE PE2025000305A patent/PE20250797A1/es unknown
- 2023-08-04 CN CN202380057750.XA patent/CN119731193A/zh active Pending
-
2025
- 2025-01-31 MX MX2025001373A patent/MX2025001373A/es unknown
- 2025-02-21 CO CONC2025/0001948A patent/CO2025001948A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2025001373A (es) | 2025-03-07 |
| CN119731193A (zh) | 2025-03-28 |
| IL318676A (en) | 2025-03-01 |
| KR20250044905A (ko) | 2025-04-01 |
| PE20250797A1 (es) | 2025-03-14 |
| AU2023317392A9 (en) | 2026-02-12 |
| US20260035407A1 (en) | 2026-02-05 |
| TW202423948A (zh) | 2024-06-16 |
| WO2024029630A1 (ja) | 2024-02-08 |
| CO2025001948A2 (es) | 2025-03-06 |
| EP4567042A1 (en) | 2025-06-11 |
| AU2023317392A1 (en) | 2025-02-20 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20260306 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20260306 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20260306 |